en

PRODUCT DETAIL

Yesafili 40 mg/ml injekčný roztok v injekčnej liekovke

Code 4389E
MA number EU/1/23/1751/002
Product Form: sol inj 1x0,1 ml/4 mg (liek.inj.skl. + ihla + striek.inj.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Biosimilar Collaborations Ireland Limited, Ireland
Therapeutic Class: 64 - OPHTHALMOLOGICA
ATC:
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01L Ocular vascular disorder agents
S01LA Antineovascularisation agents
S01LA05 Aflibercept
Shelf life: 36
Container: glass vial
Route of admin.: Intravitreal use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 15.09.2023
Validity: 15.09.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 06.12.2023
eu-flag.png sk-flag.png